Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

METAVIA INC. (MTVA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

METAVIA INC. (MTVA), most recent 12 months reported: net loss $14.45M, free cash flow -$15.7M. Latest balance sheet on file: liquid cash $12.63M. From SEC filings. Others in Pharmaceutical Preparations: MINERALYS THERAPEUTICS, INC. · Monopar Therapeutics Inc. · MapLight Therapeutics, Inc. · MATINAS BIOPHARMA HOLDINGS, INC. · NovaBridge Biosciences · NewcelX Ltd. · Minerva Neurosciences, Inc. · Neurogene Inc.

Stock screener

Watchlist